SARS-CoV-2 vaccine (Oxford Vacmedix/University of Oxford)

N/A

Report date: 2025/01/26 16:18:22

Base Information

Drug NameSARS-CoV-2 vaccine (Oxford Vacmedix/University of Oxford)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein +[5] 
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOxford Vacmedix
China Registration ClassN/A

Develop Information

Active CompaniesOxford VacmedixUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A